Видео ютуба по тегу Hcplive

HCPLive Five at ACAAI 2025
HCPLive Five at ACAAI 2025
Lebrikizumab Outcomes in Atopic Dermatitis for Patients With Skin of Color | ACAAI 2025 Interview
Lebrikizumab Outcomes in Atopic Dermatitis for Patients With Skin of Color | ACAAI 2025 Interview
What’s Next for Dapirolizumab Pegol in Lupus? | Ed Vital, MD, on Phase 3 PHOENYCS GO Trial
What’s Next for Dapirolizumab Pegol in Lupus? | Ed Vital, MD, on Phase 3 PHOENYCS GO Trial
1 Year Since the FDA Approved Epinephrine Nasal Spray
1 Year Since the FDA Approved Epinephrine Nasal Spray
Hypercortisolism in Patients with Treatment-Resistant Type 2 Diabetes, with Richard Auchus, MD, PhD
Hypercortisolism in Patients with Treatment-Resistant Type 2 Diabetes, with Richard Auchus, MD, PhD
Approaches to Rare Inherited Genetic Diseases with Roya Attar, OD
Approaches to Rare Inherited Genetic Diseases with Roya Attar, OD
Top Clinical Insights from SDPA 2025: Eczema, Alopecia, Burnout, Vitiligo, JAK Inhibitors
Top Clinical Insights from SDPA 2025: Eczema, Alopecia, Burnout, Vitiligo, JAK Inhibitors
HCPLive 5: SLEEP 2025
HCPLive 5: SLEEP 2025
Electrical Vestibular Nerve Stimulation Improves PTSD, Insomnia Symptoms
Electrical Vestibular Nerve Stimulation Improves PTSD, Insomnia Symptoms
Unmet Needs in Atopic Dermatitis and the Impact of Roflumilast Cream, with Raj Chovatiya, MD, PhD
Unmet Needs in Atopic Dermatitis and the Impact of Roflumilast Cream, with Raj Chovatiya, MD, PhD
HCPLive Five – Allergy Updates at AAAAI 2025
HCPLive Five – Allergy Updates at AAAAI 2025
Impact of Tapinarof Cream Approval for Atopic Dermatitis, with Adelaide Hebert, MD
Impact of Tapinarof Cream Approval for Atopic Dermatitis, with Adelaide Hebert, MD
More diabetes dialogue. Full episodes at hcplive.com/diabetes-dialogue
More diabetes dialogue. Full episodes at hcplive.com/diabetes-dialogue
Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD
Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD
HCPLive Five at Maui Derm NP+PA Fall 2024
HCPLive Five at Maui Derm NP+PA Fall 2024
HCPLive Five at ESC 2024
HCPLive Five at ESC 2024
Melinda Gooderham, MD: Effects of Roflumilast Foam on Scalp, Body Psoriasis
Melinda Gooderham, MD: Effects of Roflumilast Foam on Scalp, Body Psoriasis
What Do the New Roflumilast Foam Data Mean for Psoriasis Patients?
What Do the New Roflumilast Foam Data Mean for Psoriasis Patients?
Raj Chovatiya, MD, PhD: How Do Approved Eczema Treatments Compare?
Raj Chovatiya, MD, PhD: How Do Approved Eczema Treatments Compare?
HCPLive Five at ASRS 2024
HCPLive Five at ASRS 2024
Robert Bissonnette, MD: Highlighting Recent Findings on Topical Treatments for Atopic Dermatitis
Robert Bissonnette, MD: Highlighting Recent Findings on Topical Treatments for Atopic Dermatitis
HCPLive Five at ADA 2024
HCPLive Five at ADA 2024
Updates and Unmet Needs in Primary Biliary Cholangitis: An HCPLive Special Report
Updates and Unmet Needs in Primary Biliary Cholangitis: An HCPLive Special Report
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
HCPLive Five at APA 2024
HCPLive Five at APA 2024